Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Molecular Pharmacology|May 19, 2016
Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic CycleGabriel A Frank, Suneet Shukla, Prashant Rao, et al.Journal of Medicinal Chemistry|November 7, 1998
2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of actionR A Earl, R Zaczek, C A Teleha, et al.Bioorganic & Medicinal Chemistry Letters|November 18, 2004
3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitorsRamani R Ranatunge, Richard A Earl, David S Garvey, et al.Cerebral Cortex (New York, N.Y. : 1991)|June 9, 2023
Thalamo-cortical and cerebello-cortical functional connectivity in developmentCarolina Badke D'Andrea, Scott Marek, Andrew N Van, et al.Journal of Virology|June 27, 2014
Three-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmissionThao Do, Gavin Murphy, Lesley A Earl, et al.Journal of Medicinal Chemistry|December 4, 2003
Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitorsSubhash P Khanapure, David S Garvey, Delano V Young, et al.Journal of Medicinal Chemistry|May 27, 2005
3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluationSubhash P Khanapure, Michael E Augustyniak, Richard A Earl, et al.Neuroimage|August 15, 2017
Real-time motion analytics during brain MRI improve data quality and reduce costsNico U F Dosenbach, Jonathan M Koller, Eric A Earl, et al.The Journal of Biological Chemistry|July 11, 1998
Identification of a novel inhibitor of mitogen-activated protein kinase kinaseM F Favata, K Y Horiuchi, E J Manos, et al.Biochemical Pharmacology|September 20, 2005
A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methodsDelano V Young, Edward D Cochran, Vijay Dhawan, et al.Pageof 10